1
Rozenbaum, Mark H., De Cao, Elisabetta, Postma, Maarten J.
Veröffentlicht in: Rozenbaum , M H , De Cao , E & Postma , M J 2012 , ' Cost-effectiveness of pertussis booster vaccination in the Netherlands ' , Vaccine , vol. 30 , no. 50 , pp. 7327-7331 . https://doi.org/10.1016/j.vaccine.2012.06.026;
2012
Veröffentlicht in: Rozenbaum , M H , De Cao , E & Postma , M J 2012 , ' Cost-effectiveness of pertussis booster vaccination in the Netherlands ' , Vaccine , vol. 30 , no. 50 , pp. 7327-7331 . https://doi.org/10.1016/j.vaccine.2012.06.026;
2012
2
Rozenbaum, Mark H., van Hoek, Albert Jan, Hak, Eelko, Postma, Maarten J.
Veröffentlicht in: Rozenbaum , M H , van Hoek , A J , Hak , E & Postma , M J 2010 , ' Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar (R)) ' , Vaccine , vol. 28 , no. 12 , pp. 2367-2369 . https://doi.org/10.1016/j.vaccine.2010.01.005;
2010
Veröffentlicht in: Rozenbaum , M H , van Hoek , A J , Hak , E & Postma , M J 2010 , ' Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar (R)) ' , Vaccine , vol. 28 , no. 12 , pp. 2367-2369 . https://doi.org/10.1016/j.vaccine.2010.01.005;
2010
3
Tu Hong Anh T, Rozenbaum Mark H, de Boer Pieter T, Noort Albert C, Postma Maarten J
Veröffentlicht in: BMC Infectious Diseases, Vol 13, Iss 1, p 54 (2013);
2013
Veröffentlicht in: BMC Infectious Diseases, Vol 13, Iss 1, p 54 (2013);
2013
4
Stevanovic, Jelena, Pompen, Marjolein, Le, Hoa H., Rozenbaum, Mark H., Tieleman, Robert G., Postma, Maarten J.
Veröffentlicht in: Stevanovic , J , Pompen , M , Le , H H , Rozenbaum , M H , Tieleman , R G & Postma , M J 2014 , ' Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands ' , PLoS ONE , vol. 9 , no. 8 , e103974 . https://doi.org/10.1371/journal.pone.0103974;
2014
Veröffentlicht in: Stevanovic , J , Pompen , M , Le , H H , Rozenbaum , M H , Tieleman , R G & Postma , M J 2014 , ' Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands ' , PLoS ONE , vol. 9 , no. 8 , e103974 . https://doi.org/10.1371/journal.pone.0103974;
2014
5
6
Hak Eelko, Wilschut Jan C, Giaquinto Carlo, Mangen Marie-Josee J, Rozenbaum Mark H, Postma Maarten J
Veröffentlicht in: BMC Public Health, Vol 11, Iss 1, p 462 (2011);
2011
Veröffentlicht in: BMC Public Health, Vol 11, Iss 1, p 462 (2011);
2011
7
van der Schans, Simon, Vondeling, Gert T, Cao, Qi, van der Pol, Simon, Visser, Sipke, Postma, Maarten J, Rozenbaum, Mark H
Veröffentlicht in: van der Schans , S , Vondeling , G T , Cao , Q , van der Pol , S , Visser , S , Postma , M J & Rozenbaum , M H 2020 , ' The impact of patent expiry on drug prices : insights from the Dutch market ' , Journal of market access & health policy , vol. 9 , no. 1 , 1849984 . https://doi.org/10.1080/20016689.2020.1849984;
2020
Veröffentlicht in: van der Schans , S , Vondeling , G T , Cao , Q , van der Pol , S , Visser , S , Postma , M J & Rozenbaum , M H 2020 , ' The impact of patent expiry on drug prices : insights from the Dutch market ' , Journal of market access & health policy , vol. 9 , no. 1 , 1849984 . https://doi.org/10.1080/20016689.2020.1849984;
2020
8
Urbanus, Anouk T., van Keep, Marjolijn, Matser, Amy A., Rozenbaum, Mark H., Weegink, Christine J., van den Hoek, Anneke, Prins, Maria, Postma, Maarten J.
Veröffentlicht in: Urbanus , A T , van Keep , M , Matser , A A , Rozenbaum , M H , Weegink , C J , van den Hoek , A , Prins , M & Postma , M J 2013 , ' Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective? ' , PLoS ONE , vol. 8 , no. 8 , e70319 . https://doi.org/10.1371/journal.pone.0070319;
2013
Veröffentlicht in: Urbanus , A T , van Keep , M , Matser , A A , Rozenbaum , M H , Weegink , C J , van den Hoek , A , Prins , M & Postma , M J 2013 , ' Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective? ' , PLoS ONE , vol. 8 , no. 8 , e70319 . https://doi.org/10.1371/journal.pone.0070319;
2013
9
10
Wagenvoort, Gertjan H. J., Knol, Mirjam J., de Melker, Hester E., Vlaminckx, Bart J., van der Ende, Arie, Rozenbaum, Mark H., Sanders, Elisabeth A. M.
Veröffentlicht in: Wagenvoort , G H J , Knol , M J , de Melker , H E , Vlaminckx , B J , van der Ende , A , Rozenbaum , M H & Sanders , E A M 2016 , ' Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands ' , Vaccine , vol. 34 , no. 3 , pp. 334-340 . https://doi.org/10.1016/j.vaccine.2015.11.048;
2016
Veröffentlicht in: Wagenvoort , G H J , Knol , M J , de Melker , H E , Vlaminckx , B J , van der Ende , A , Rozenbaum , M H & Sanders , E A M 2016 , ' Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands ' , Vaccine , vol. 34 , no. 3 , pp. 334-340 . https://doi.org/10.1016/j.vaccine.2015.11.048;
2016